تقرير
Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)
| العنوان: | Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M) |
|---|---|
| المصدر: | MATCH Treatment Subprotocol M: Phase II Study of MLN0128 (Tak-228) in Patients With Tumors With TSC1 or TSC2 Mutations |
| الوصول الحر: | https://clinicaltrials.gov/ct2/show/NCT06390865Test |
| قاعدة البيانات: | ClinicalTrials.gov |
| الوصف غير متاح. |